AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
FibroBiologics, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01K4MB4V6
0.95▼ 0.07 (-6.86%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
1.02
Day's Range
0.95 – 1.02
52-Week Range
0.19 – 4.18
Volume
111.8K
Avg Volume
144.7K
Share Statistics
Shares Outstanding
Employees
15
Exchange
XNAS
Listed
2024-01-31
Share count as of July 31, 2026

FibroBiologics, Inc. Common Stock (FBLG) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about FibroBiologics, Inc. Common Stock (FBLG)
What is FibroBiologics, Inc. Common Stock's Market Cap?
FibroBiologics, Inc. Common Stock's Market Cap is $6.3M, based on as-reported figures from SEC (XBRL) filings.
What is FibroBiologics, Inc. Common Stock's Net Income (TTM)?
FibroBiologics, Inc. Common Stock's Net Income (TTM) is -$18.1M, based on as-reported figures from SEC (XBRL) filings.
What is FibroBiologics, Inc. Common Stock's EBITDA?
FibroBiologics, Inc. Common Stock's EBITDA is -$16.5M, based on as-reported figures from SEC (XBRL) filings.
What is FibroBiologics, Inc. Common Stock's Diluted EPS (TTM)?
FibroBiologics, Inc. Common Stock's Diluted EPS (TTM) is -2.72, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · FBLGAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023
Operating expenses:
Research and development
General, administrative and other
Total operating expenses
Loss from operations
Other income/(expense):
Change in fair value of warrant liability————
Change in fair value of forward contract liability————
Change in fair value of SEPA put option liability
Change in fair value of convertible debt
Commitment fee expenses————
Other expense——
Interest income
Interest expense
Total other expense
Net loss
Net income (loss) attributable to common stockholders————
Net loss per share, basic
Net loss per share, diluted